Skip to main content
ScienceReportedHighDevelopingFeatured
6.7

First In-Body Prime Editing Trial Targets Wilson's Disease Mutation

Researchers have administered prime editing directly in a patient's body for the first time, aiming to correct the genetic mutation causing Wilson's disease. The procedure's efficiency and safety remain unproven, pending clinical evaluation. This marks a milestone in gene therapy, potentially lowering costs and time for genetic treatments.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works

Digi24about 7 hours agoCredibility 33%View source

Score Breakdown

Mosaic Score6.7
Model confidence0.5
Significance0.8
Source credibility0.3
Source

Related signals

8 found